Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Chun

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Histopathology|September 6, 2013
PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancerInga Cordes, Martina Kluth, Dominika Zygis, et al.
BMC Cancer|January 5, 2020
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)Sebastian C Schmid, Florestan J Koll, Claus Rödel, et al.
Urologia Internationalis|November 28, 2018
Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity IndexesSami-Ramzi Leyh-Bannurah, Emanuele Zaffuto, Paolo Dell'Oglio, et al.
Urologic Oncology|December 18, 2017
Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratificationSami-Ramzi Leyh-Bannurah, Lars Budäus, Emanuele Zaffuto, et al.
The Prostate|September 30, 2016
Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer PatientsSami-Ramzi Leyh-Bannurah, Stéphanie Gazdovich, Lars Budäus, et al.
The Prostate|January 18, 2017
North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate CancerSami-Ramzi Leyh-Bannurah, Lars Budäus, Raisa Pompe, et al.
The Journal of Urology|April 3, 2013
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trialPaolo Gontero, Marco Oderda, Anja Mehnert, et al.
Cell Reports. Medicine|May 2, 2022
Single-cell proteomics defines the cellular heterogeneity of localized prostate cancerLaura De Vargas Roditi, Andrea Jacobs, Jan H Rueschoff, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 9, 2023
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trialDavid Krug, Detlef Imhoff, Alfred Haidenberger, et al.
European Urology|April 8, 2017
Local Therapy Improves Survival in Metastatic Prostate CancerSami-Ramzi Leyh-Bannurah, Stéphanie Gazdovich, Lars Budäus, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Histopathology|September 6, 2013
PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancerInga Cordes, Martina Kluth, Dominika Zygis, et al.
BMC Cancer|January 5, 2020
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)Sebastian C Schmid, Florestan J Koll, Claus Rödel, et al.
Urologia Internationalis|November 28, 2018
Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity IndexesSami-Ramzi Leyh-Bannurah, Emanuele Zaffuto, Paolo Dell'Oglio, et al.
Urologic Oncology|December 18, 2017
Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratificationSami-Ramzi Leyh-Bannurah, Lars Budäus, Emanuele Zaffuto, et al.
The Prostate|September 30, 2016
Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer PatientsSami-Ramzi Leyh-Bannurah, Stéphanie Gazdovich, Lars Budäus, et al.
The Prostate|January 18, 2017
North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate CancerSami-Ramzi Leyh-Bannurah, Lars Budäus, Raisa Pompe, et al.
The Journal of Urology|April 3, 2013
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trialPaolo Gontero, Marco Oderda, Anja Mehnert, et al.
Cell Reports. Medicine|May 2, 2022
Single-cell proteomics defines the cellular heterogeneity of localized prostate cancerLaura De Vargas Roditi, Andrea Jacobs, Jan H Rueschoff, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 9, 2023
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trialDavid Krug, Detlef Imhoff, Alfred Haidenberger, et al.
European Urology|April 8, 2017
Local Therapy Improves Survival in Metastatic Prostate CancerSami-Ramzi Leyh-Bannurah, Stéphanie Gazdovich, Lars Budäus, et al.
Pageof 6